Cargando…
Probucol plus cilostazol attenuate hypercholesterolemia-induced exacerbation in ischemic brain injury via anti-inflammatory effects
Probucol, a lipid-lowering agent with anti-oxidant properties, is involved in protection against atherosclerosis, while cilostazol, an antiplatelet agent, has diverse neuroprotective properties. In this study, we investigated the anti-inflammatory effects of probucol and cilostazol on focal cerebral...
Autores principales: | KIM, JI HYUN, HONG, KI WHAN, BAE, SUN SIK, SHIN, YONG-IL, CHOI, BYUNG TAE, SHIN, HWA KYOUNG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121353/ https://www.ncbi.nlm.nih.gov/pubmed/25017431 http://dx.doi.org/10.3892/ijmm.2014.1848 |
Ejemplares similares
-
Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits
por: Wang, Yanli, et al.
Publicado: (2015) -
Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke
por: Kim, Yu Ri, et al.
Publicado: (2017) -
Combined Therapeutic Effect of Probucol and Cilostazol on Endothelial Function in Patients with Silent Cerebral Lacunar Infarcts and Hypercholesterolemia: A Preliminary Study
por: Takase, Bonpei, et al.
Publicado: (2013) -
Cilostazol and Probucol for Cognitive Decline after Stroke: A Cognitive Outcome Substudy of the PICASSO Trial
por: Lim, Jae-Sung, et al.
Publicado: (2021) -
Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal Cells
por: Lee, Hye Rin, et al.
Publicado: (2015)